In specific instances of severe drug-induced agranulocytosis, granulocyte colony-stimulating factor (GCSF) filgrastim has been employed as an adjunctive therapy, as it may expedite the recovery of neutrophils [8]. This evidence concerns the gene CSF3 and Absence of circulating granulocytes.